By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tillotts Pharma AG 

Hauptstrasse 27

Ziefen    4417  Switzerland
Phone: 41-61-935-2626 Fax: 41-61-935 2625



Company News
Tillotts Pharma AG's Parent Company Zeria Pharmaceutical Co., Ltd. Launches Zentacort 3mg Capsules In Japan For Treatment In Crohn's Disease 12/14/2016 10:07:06 AM
Tillotts Pharma AG Introduces The New Technology OPTICORE (OPTImized COlonic RElease) For Colonic Targeting Of Active Molecules For The Treatment Of Any Colon Disease 11/21/2016 9:59:59 AM
Tillotts Pharma AG's Parent Company Zeria Pharmaceutical Co., Ltd. Receives Approval For Zentacort 3mg Capsules In Japan 10/6/2016 9:55:11 AM
PendoPharm Inc. To Distribute ENTOCORT (Budesonide) In Canada For Tillotts Pharma AG 9/28/2016 6:53:22 AM
Recipharm AB Establishes Long Term Supply Agreement With Tillotts Pharma AG 8/31/2016 9:39:15 AM
Tillotts Pharma AG Under Agreement To Acquire Global Rights For Entocort (Budesonide) From AstraZeneca PLC (AZN) Outside The U.S. 7/9/2015 9:16:51 AM
Tillotts Pharma AG And Numab AG Announce Exclusive Development And Licensing Agreement For TNF-Alpha Blockers As Drug Candidates For Inflammatory Bowel Disease 6/9/2015 6:22:16 AM
Cancer Prevention Pharmaceuticals, Inc. And Tillotts Pharma AG Sign Licensing Agreement For CPP-1X/Sulindac In Europe And Japan 1/10/2014 9:28:02 AM
Tillotts Pharma AG and MediSafe Partner to Go Beyond the Tablet With UCandME™ Program 10/17/2013 10:01:58 AM
Augurix SA and Tillotts Pharma AG Sign Agreement for the Commercialization of Simtomax(R) for Rapid Diagnosis of Celiac Disease 9/7/2011 11:00:41 AM